Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -W-
04.02.2020 12:42:38

Bio-Techne Corp. Q2 Adj. Profit Rises; Organic Revenue Up 6% - Quick Facts

(RTTNews) - Bio-Techne Corp. (TECH) reported second-quarter adjusted EPS of $1.08, compared to $1.06 last year, an increase of 2%, despite foreign currency exchange headwinds negatively impacting results by $0.08. On average, 8 analysts polled by Thomson Reuters expected the company to report profit per share of $1.13, for the quarter. Analysts' estimates typically exclude special items. Adjusted operating income increased 9% from previous year.

Second-quarter net sales increased 6% year-on-year to $184.9 million. Organic growth was 6%, for the quarter. Analysts expected revenue of $191.24 million for the quarter. Diagnostics and Genomics recorded organic growth of 12% in the second quarter.

Bio-Techne Corp. announced that its Board has decided to pay a dividend of $0.32 per share for the quarter ended December 31, 2019. The quarterly dividend will be payable February 28, 2020 to all common shareholders of record on February 14, 2020.

Analysen zu Bio-Techne Corpmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Bio-Techne Corp 67,50 3,85% Bio-Techne Corp